Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, September 06, 2013
Micromeritics Instrument Corporation is proud to announce its national accreditation as a Post-Secondary Avocational/Professional Development Institution by the Accrediting Council for Continuing Education and Training (ACCET), an accrediting agency ...
read more
Thursday, February 24, 2022
Contract development and manufacturing organisation Micro-Sphere has invested more than €1.5 million at its plant in Switzerland to expand its offering in encapsulation for inhalation products.
read more
Mikart LLC, a comprehensive contract development and manufacturing organization, acquired a state-of-the-art Korsch XM12 to meet their Pharmaceutical client demands for complex formulation development and production of oral solid dose products.
read more
To meet the high demand for lipids, a key component of mRNA-based vaccines and therapeutics, MilliporeSigma has launched a new, high-purity synthetic cholesterol product, nine months ahead of schedule. “Tapping into two decades’ experience of ...
read more
Monday, September 14, 2020
MilliporeSigma announced a $65 million expansion of its HPAPI and ADC manufacturing capabilities and capacity at its facility near Madison, Wisconsin.
read more
Wednesday, December 27, 2017
MilliporeSigma announced a collaboration with IPS-Integrated Project Services and G-CON to provide 2,000L MAb facility and single-use process technology platform.
read more
Thursday, October 14, 2021
MilliporeSigma announced the opening of its second Carlsbad, California-based facility, significantly expanding its CDMO footprint. This new $110 million, 140,000-square foot facility will more than double the Life Science business sector's existing ...
read more
MilliporeSigma announced a new collaboration with Angiex to support the biotechnology start-up's ability to speed its lead oncology antibody drug candidate to clinical use.
read more
Thursday, October 10, 2019
MilliporeSigma has acquired FloDesign Sonics, developer of an acoustic cell processing platform for the industrialization of cell and gene therapy manufacturing.
read more
Wednesday, February 21, 2018
MilliporeSigma announced an additional investment of $50 million to build a robust manufacturing and distribution platform in Asia over a span of two years.
read more
Wednesday, October 11, 2017
MilliporeSigma today officially opened its new Life Science Center in Burlington, Massachusetts.
read more
MilliporeSigma has doubled its high-potent active pharmaceutical ingredients (HPAPI) production capacity with the expansion of its facility in Verona, near Madison, Wisconsin, USA. This new US$65 million, 70,000 square foot facility, officially ...
read more
Thursday, December 21, 2017
MilliporeSigma has signed a commercial supply agreement to manufacture viral vectors for bluebird bio, for its use in gene therapies.
read more
MilliporeSigma and The Jenner Institute announced The Jenner Institute has laid the foundation for large-scale production of its Covid-19 vaccine candidate, ChAdOx1 nCoV-19.
read more
MilliporeSigma has formed a strategic alliance with Baylor College of Medicine for Vaccine Development to advance vaccine research and development for neglected and emerging infections.
read more